Dentsply Sirona Analyst Price Targets

Wall Street analyst price targets and consensus rating for Dentsply Sirona (XRAY).

Price Target Range — 13 Quarters

Analyst Consensus — 18 Analysts

4Buy

12Hold

2Sell

Consensus RatingNeutral# Analysts18Avg. Consensus PT$16Upside to Avg. PT+80.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 9, 2026	Piper Sandler	Jason Bednar	PT Cut	Neutral	$14→$12
Sep 17, 2026	BMO Capital	Vik Chopra	PT Cut	Market Perform	$13→$10
Aug 24, 2026	Barclays	Glen Santangelo	PT Raise	Underweight	$9→$11
Jul 29, 2026	Piper Sandler	Jason Bednar	PT Raise	Neutral	$13→$14
Jul 9, 2026	BMO Capital	—	Initiate	Market Perform	$12
Jun 4, 2026	Barclays	Glen Santangelo	PT Cut	Underweight	$12→$9
May 7, 2026	UBS	Kevin Caliendo	PT Cut	Buy	$18→$17
May 6, 2026	Mizuho	Steven Valiquette	PT Cut	Neutral	$16→$14
Apr 15, 2026	Citigroup	Daniel Grosslight	Initiate	Sell	$10
Mar 2, 2026	Mizuho	Steven Valiquette	PT Raise	Neutral	$14→$16
Mar 2, 2026	Barrington Research	Michael Petusky	PT Raise	Outperform	$14→$17
Feb 27, 2026	Wells Fargo	Vik Chopra	PT Raise	Equal-Weight	$12→$13
Feb 27, 2026	Evercore ISI Group	Elizabeth Anderson	PT Raise	In-Line	$12→$15
Feb 27, 2026	Baird	Jeffrey Johnson	PT Raise	Neutral	$12→$14
Feb 19, 2026	B of A Securities	Michael Cherny	Upgrade	Neutral→Buy	$13→$17
Feb 3, 2026	UBS	Kevin Caliendo	PT Cut	Buy	$17→$16
Jan 20, 2026	Mizuho	Steven Valiquette	PT Raise	Neutral	$13→$14
Jan 5, 2026	Barrington Research	Michael Petusky	Maintained	Outperform	$14
Dec 16, 2025	Barrington Research	Michael Petusky	Maintained	Outperform	$14
Dec 16, 2025	Baird	Jeffrey Johnson	PT Cut	Neutral	$14→$12

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Piper Sandler Maintains Neutral on Dentsply Sirona, Lowers Price Target to $12

Piper Sandler analyst Jason Bednar maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from $14 to $12.

Benzinga Newsdesk

PRO
BMO Capital Maintains Market Perform on Dentsply Sirona, Lowers Price Target to $10

BMO Capital analyst Vik Chopra maintains Dentsply Sirona (NASDAQ:XRAY) with a Market Perform and lowers the price target from $13 to $10.

Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Dentsply Sirona, Raises Price Target to $11

Barclays analyst Glen Santangelo maintains Dentsply Sirona (NASDAQ:XRAY) with a Underweight and raises the price target from $9 to $11.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Neutral on Dentsply Sirona, Raises Price Target to $14

Piper Sandler analyst Jason Bednar maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and raises the price target from $13 to $14.

Benzinga Newsdesk

PRO
BMO Capital Initiates Coverage On Dentsply Sirona with Market Perform Rating, Announces Price Target of $12

BMO Capital initiates coverage on Dentsply Sirona (NASDAQ:XRAY) with a Market Perform rating and announces Price Target of $12.

Benzinga Newsdesk

Wall Street's Most Accurate Analysts Give Their Take On 3 Healthcare Stocks Delivering High-Dividend Yields

In turbulent markets, investors turn to dividend-yielding stocks. Here are analyst ratings for high-yielding energy stocks.

Avi Kapoor

Dentsply Sirona Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Dentsply Sirona Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Piper Sandler Maintains Neutral on Dentsply Sirona, Lowers Price Target to $12

PRO
BMO Capital Maintains Market Perform on Dentsply Sirona, Lowers Price Target to $10

PRO
Barclays Maintains Underweight on Dentsply Sirona, Raises Price Target to $11

PRO
Piper Sandler Maintains Neutral on Dentsply Sirona, Raises Price Target to $14

PRO
BMO Capital Initiates Coverage On Dentsply Sirona with Market Perform Rating, Announces Price Target of $12

Wall Street's Most Accurate Analysts Give Their Take On 3 Healthcare Stocks Delivering High-Dividend Yields

People Also Watch

People Also Watch

Dentsply Sirona Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Dentsply Sirona Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROPiper Sandler Maintains Neutral on Dentsply Sirona, Lowers Price Target to $12

PROBMO Capital Maintains Market Perform on Dentsply Sirona, Lowers Price Target to $10

PROBarclays Maintains Underweight on Dentsply Sirona, Raises Price Target to $11

PROPiper Sandler Maintains Neutral on Dentsply Sirona, Raises Price Target to $14

PROBMO Capital Initiates Coverage On Dentsply Sirona with Market Perform Rating, Announces Price Target of $12

Wall Street's Most Accurate Analysts Give Their Take On 3 Healthcare Stocks Delivering High-Dividend Yields

People Also Watch

People Also Watch

PRO
Piper Sandler Maintains Neutral on Dentsply Sirona, Lowers Price Target to $12

PRO
BMO Capital Maintains Market Perform on Dentsply Sirona, Lowers Price Target to $10

PRO
Barclays Maintains Underweight on Dentsply Sirona, Raises Price Target to $11

PRO
Piper Sandler Maintains Neutral on Dentsply Sirona, Raises Price Target to $14

PRO
BMO Capital Initiates Coverage On Dentsply Sirona with Market Perform Rating, Announces Price Target of $12